Fayez Sarofim & CO Astrazeneca PLC Transaction History
Fayez Sarofim & CO
- $39.8 Billion
- Q4 2024
A detailed history of Fayez Sarofim & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Fayez Sarofim & CO holds 3,643,010 shares of AZN stock, worth $279 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
3,643,010
Previous 3,444,033
5.78%
Holding current value
$279 Million
Previous $268 Million
11.06%
% of portfolio
0.6%
Previous 0.69%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,367Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.62 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.14 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.87 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.83 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.84 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $237B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...